Correction: Ivarmacitinib for Atopic Dermatitis with Prurigo Nodularis-like Lesions and Alopecia Areata: A Case Study

By
Xiaofan Liao
Yuan Lu
August 18, 2026

Frontiers In Immunology

Background

Atopic dermatitis is a chronic inflammatory skin condition that can lead to significant morbidity. Accurate reporting of clinical findings is essential for guiding future research.

Data Highlights

No numerical or trial data is presented in this correction.

Key Findings

The correction addresses an error in the figure captions of the original article.
Histopathological analysis revealed significant epidermal thickening with hyperkeratosis and acanthosis.
A moderately dense inflammatory infiltrate was noted in the superficial and mid-dermis.
Lymphocytes predominated within the inflammatory infiltrate, with occasional eosinophils.
The original article has been updated to reflect these corrections.

Clinical Implications

Clinicians should be aware of the importance of accurate histopathological reporting in the management of atopic dermatitis. Understanding the inflammatory profile can aid in tailoring treatment strategies.

Conclusion

This correction emphasizes the need for precision in clinical reporting, which is vital for advancing treatment protocols in atopic dermatitis.

Correction: Ivarmacitinib for Atopic Dermatitis with Prurigo Nodularis-like Lesions and Alopecia Areata: A Case Study